GLB1 Antibody / Beta galactosidase

Deficiency of GLB1 activity is associated with lysosomal storage disorders such as GM1 gangliosidosis and Morquio B disease. These conditions highlight the importance of GLB1 in cellular homeostasis and human health. Employing a GLB1 antibody enables detection of protein expression and activity in both normal physiology and disease contexts. NSJ Bioreagents provides a high-quality GLB1 antibody validated for applications including western blot, immunohistochemistry, and immunofluorescence. Using a GLB1 antibody ensures sensitive and reproducible results for studies of lysosomal biology, enzymatic function, and inherited metabolic disorders.